Ischemic Optic Neuropathy Clinical Trials

7 recruitingLast updated: May 13, 2026

There are 7 actively recruiting ischemic optic neuropathy clinical trials across 7 countries. Studies span Not Applicable, Phase 1. Top locations include Charleston, South Carolina, United States, Coral Springs, Florida, United States, Dubai, United Arab Emirates, United Arab Emirates. Updated daily from ClinicalTrials.gov.


Ischemic Optic Neuropathy Trials at a Glance

7 actively recruiting trials for ischemic optic neuropathy are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Charleston, Coral Springs, and Dubai. Lead sponsors running ischemic optic neuropathy studies include Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal, Life Biosciences Inc., and ASST Fatebenefratelli Sacco.

Browse ischemic optic neuropathy trials by phase

Treatments under study

About Ischemic Optic Neuropathy Clinical Trials

Looking for clinical trials for Ischemic Optic Neuropathy? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ischemic Optic Neuropathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ischemic Optic Neuropathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis

Giant Cell Arteritis (GCA)Ischemic Optic NeuropathyNAION - Non-Arteritic Ischemic Optic Neuropathy
Rigshospitalet, Denmark122 enrolled1 locationNCT07206238
Recruiting
Phase 1

Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)

Open-angle Glaucoma (OAG)NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)
Life Biosciences Inc.18 enrolled4 locationsNCT07290244
Recruiting
Not Applicable

New Non-invasive Modalities for Assessing Retinal Structure and Function

HemianopiaLeber Hereditary Optic NeuropathyIschemic Optic Neuropathy+2 more
Randy Kardon500 enrolled1 locationNCT03475173
Recruiting

Optic Nerve Sheath Ultrasound in Giant Cell Arteritis

Giant Cell ArteritisAnterior Ischemic Optic NeuropathyOptic Neuropathy, Ischemic
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal285 enrolled6 locationsNCT05749094
Recruiting
Not Applicable

Optic Nerve Injury in Obstructive Sleep Apnea Patients

Obstructive Sleep Apnea (OSA)Ischemic Optic Neuropathy/Optic Nerve Stroke
Nanjing Medical University80 enrolled1 locationNCT06748703
Recruiting
Not Applicable

Stem Cell Ophthalmology Treatment Study II

Age-Related Macular DegenerationRetinitis PigmentosaMacular Degeneration+15 more
MD Stem Cells500 enrolled4 locationsNCT03011541
Recruiting

Visual Involvement in Giant Cell Arteritis

Retinal ischemiacentral retinal artery occlusionGiant Cell Arteritis+6 more
ASST Fatebenefratelli Sacco762 enrolled1 locationNCT06500728